Dr. Dormer is a pharmaceutical scientist and bioengineer with over a decade of experience developing microsphere-based solid oral and parenteral/implantable dosage forms, with an emphasis on controlled release and other innovative formulation concepts. He is responsible for pharmaceutical development activities such as creation of prototypes, analytical method development, CMC and IP documentation, pharmacokinetic correlations, tech transfer, manufacture of clinical supplies, and commercial scale process optimization and validation. Dr. Dormer received his B.S. in Chemical Engineering and his Ph.D. with Honors in Bioengineering, both from The University of Kansas.

Biplob Mitra holds B. Pharm. (Hons.) and M. Pharm. degrees from Dhaka University in Bangladesh and Ph.D. in Industrial and Physical Pharmacy from Purdue University in Indiana. Biplob has over 15 years of experience, at Lilly and BMS, in developing clinical and commercial formulations and manufacturing processes for small molecule drug products. His research interests focus on patient centric drug development, design and optimization of micro-/mini-tablets, novel formulations and processes enabling micro-dosing, and mechanistic understanding of granulation and compression.

Jason Teckoe received his B.Sc. in chemistry from the University of Warwick (UK), followed by a M.Sc. in polymer science from the University of Lancaster (UK) and Ph.D. in polymer physics from the University of Reading (UK).  Jason has over 20 years’ experience formulating novel solid oral dosage forms and film coatings systems and is a named inventor on several patents.  Jason joined Colorcon in 2007, as Senior Manager - New Product Development, based in Harleysville, PA, USA, where he led the innovative development of Colorcon’s film coating systems.  Since 2017, Jason has been back in the UK based in Colorcon’s regional HQ in Dartford, where he heads up the Technical Team.

Speaker4Bio

Speaker5Bio